The tumour suppressor gene PTEN (also called MMAC1 and TEP1) is somatically mutated in a variety of cancer types. In addition, germline mutation of PTEN is responsible for two dominantly-inherited related cancer syndromes called Cowden disease and Bannayan-Ruvalcaba-Riley syndrome. The PTEN gene encodes a dual-specificity phosphatase which inhibits cell spreading and migration partly through the inhibition of the integrin-mediated signalling. Furthermore, PTEN regulates the levels of phosphatidylinositol 3, 4, 5-trisphosphate (PIP3) by specifically dephosphorylating position 3 on the inositol ring. We report here that the dauer formation gene
daf-18 is the Caenorhabditis elegans homologue of PTEN. DAF-18 is a component of the insulin-like signalling pathway controlling entry into diapause and adult longevity that is regulated by the DAF-2 receptor tyrosine kinase and the AGE-1 PI3 kinase. We found that the
daf-18 (
e1375) mutation within the PTEN homologue results in the generation of a premature stop codon. Others have shown that the
daf-18 mutation suppresses the life-extension and constitutive dauer formation associated with
daf-2 or
age-1 mutants. Similarly, we show that inactivation of
daf-18 by RNA-mediated interference mimics this suppression, and that a wild type
daf-18 transgene rescues the
daf-18 dauer defect. These results indicate that the PTEN/DAF-18 antagonizes the DAF-2/AGE-1 pathway, perhaps by catalyzing the dephosphorylation of PIP3 generated by AGE-1. These data further support the notion that mutations of PTEN contribute to the development of human neoplasia through an aberrant activation of the PI3K-Akt/PKB signalling cascade.